Interictal and Postictal Contingent Negative Variation in Migraine Without Aura
Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy co...
Gespeichert in:
Veröffentlicht in: | Headache 2001-01, Vol.41 (1), p.72-78 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 78 |
---|---|
container_issue | 1 |
container_start_page | 72 |
container_title | Headache |
container_volume | 41 |
creator | Mulder, E.J.C.M. Linssen, W.H.J.P. Passchier, J. De Geus, E.J.C. |
description | Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy controls during an attack. This study aimed to replicate the interictal findings, and additionally examine whether migraineurs show reduced CNV amplitudes during the postattack period. Of 12 patients with migraine without aura and their sex‐ and age‐matched healthy controls, CNV characteristics were recorded once in an interictal period, once during the postattack period within 30 hours after an attack that was treated with sumatriptan, and once after an attack that was treated with habitual nonvasoactive medication (counterbalanced). The present results did not confirm the enhanced CNV early and late wave amplitudes or impaired habituation, and cortical hyperexcitability that have previously been reported in the interictal period in patients with migraine without aura. During the postattack period, a decrease in CNV early and late amplitudes was found but only after sumatriptan use. This reduction in CNV amplitudes was most prominent over the frontal cortex and could reflect cortical hypoexcitability, possibly related to a suppression of central catecholaminergic activity by sumatriptan. |
doi_str_mv | 10.1046/j.1526-4610.2001.111006072.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70607399</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>74823280</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5269-f99af9f985f5e9a618d0c21820db0688ce13586d9d51305f3ad0e0a585968ed43</originalsourceid><addsrcrecordid>eNqVkF9P2zAUxS20CTrgK6CIob2lu07if9Jeqo4BWymVYOPRMolT3KUOs52tfPs5SlUk3niyr-_vnHt9EDrDMMZQ0M-rMSYZTQsaHzIAPMYYA1Bg2Xizh0a75js0il2WclbwA_TB-xVA1Au6jw6ihHIKdIRurmzQzpRBNYmyVbJofRiqaWuDsUttQzLXSxXMX538Us7EW2sTY5Nrs3TKWJ3cm_DYdiGZdE4dofe1arw-3p6H6Oe387vpZTq7ubiaTmZpGfcTaS2EqkUtOKmJFopiXkGZYZ5B9QCU81LjnHBaiYrgHEidqwo0KMKJoFxXRX6IPg2-T67902kf5Nr4UjeNsrrtvGR9IrkQETx9Ba7aztm4m4zzaMEwyyL0ZYBK13rvdC2fnFkr9ywxyD51uZJ9sLIPVvapy13qchPlJ9sZ3cNaVy_ibcwR-LgFlC9VUztlS-N3HGcYExap6UD9M41-ftMK8vJ88hVi2X84HVyMD3qzc1Hut6QsZ0Tezy_k4nb24_v8diEX-X-CTKxk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218647172</pqid></control><display><type>article</type><title>Interictal and Postictal Contingent Negative Variation in Migraine Without Aura</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><creator>Mulder, E.J.C.M. ; Linssen, W.H.J.P. ; Passchier, J. ; De Geus, E.J.C.</creator><creatorcontrib>Mulder, E.J.C.M. ; Linssen, W.H.J.P. ; Passchier, J. ; De Geus, E.J.C.</creatorcontrib><description>Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy controls during an attack. This study aimed to replicate the interictal findings, and additionally examine whether migraineurs show reduced CNV amplitudes during the postattack period. Of 12 patients with migraine without aura and their sex‐ and age‐matched healthy controls, CNV characteristics were recorded once in an interictal period, once during the postattack period within 30 hours after an attack that was treated with sumatriptan, and once after an attack that was treated with habitual nonvasoactive medication (counterbalanced). The present results did not confirm the enhanced CNV early and late wave amplitudes or impaired habituation, and cortical hyperexcitability that have previously been reported in the interictal period in patients with migraine without aura. During the postattack period, a decrease in CNV early and late amplitudes was found but only after sumatriptan use. This reduction in CNV amplitudes was most prominent over the frontal cortex and could reflect cortical hypoexcitability, possibly related to a suppression of central catecholaminergic activity by sumatriptan.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1046/j.1526-4610.2001.111006072.x</identifier><identifier>PMID: 11168606</identifier><identifier>CODEN: HEADAE</identifier><language>eng</language><publisher>Boston, MA, USA: Blackwell Science Inc</publisher><subject>Adult ; Biological and medical sciences ; Cardiovascular system ; Central Nervous System - drug effects ; Cerebral Cortex - physiopathology ; Contingent Negative Variation ; Female ; Humans ; Male ; Medical sciences ; migraine ; Migraine without Aura - drug therapy ; Migraine without Aura - physiopathology ; Pharmacology. Drug treatments ; Serotonin Receptor Agonists - pharmacology ; Serotonin Receptor Agonists - therapeutic use ; sumatriptan ; Sumatriptan - pharmacology ; Sumatriptan - therapeutic use ; Task Performance and Analysis ; Vasodilator agents. Cerebral vasodilators</subject><ispartof>Headache, 2001-01, Vol.41 (1), p.72-78</ispartof><rights>2001 INIST-CNRS</rights><rights>Copyright Blackwell Publishing Ltd. Jan 2001</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5269-f99af9f985f5e9a618d0c21820db0688ce13586d9d51305f3ad0e0a585968ed43</citedby><cites>FETCH-LOGICAL-c5269-f99af9f985f5e9a618d0c21820db0688ce13586d9d51305f3ad0e0a585968ed43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1526-4610.2001.111006072.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1526-4610.2001.111006072.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,4014,27914,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=871157$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11168606$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mulder, E.J.C.M.</creatorcontrib><creatorcontrib>Linssen, W.H.J.P.</creatorcontrib><creatorcontrib>Passchier, J.</creatorcontrib><creatorcontrib>De Geus, E.J.C.</creatorcontrib><title>Interictal and Postictal Contingent Negative Variation in Migraine Without Aura</title><title>Headache</title><addtitle>Headache: The Journal of Head and Face Pain</addtitle><description>Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy controls during an attack. This study aimed to replicate the interictal findings, and additionally examine whether migraineurs show reduced CNV amplitudes during the postattack period. Of 12 patients with migraine without aura and their sex‐ and age‐matched healthy controls, CNV characteristics were recorded once in an interictal period, once during the postattack period within 30 hours after an attack that was treated with sumatriptan, and once after an attack that was treated with habitual nonvasoactive medication (counterbalanced). The present results did not confirm the enhanced CNV early and late wave amplitudes or impaired habituation, and cortical hyperexcitability that have previously been reported in the interictal period in patients with migraine without aura. During the postattack period, a decrease in CNV early and late amplitudes was found but only after sumatriptan use. This reduction in CNV amplitudes was most prominent over the frontal cortex and could reflect cortical hypoexcitability, possibly related to a suppression of central catecholaminergic activity by sumatriptan.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Central Nervous System - drug effects</subject><subject>Cerebral Cortex - physiopathology</subject><subject>Contingent Negative Variation</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>migraine</subject><subject>Migraine without Aura - drug therapy</subject><subject>Migraine without Aura - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Serotonin Receptor Agonists - therapeutic use</subject><subject>sumatriptan</subject><subject>Sumatriptan - pharmacology</subject><subject>Sumatriptan - therapeutic use</subject><subject>Task Performance and Analysis</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF9P2zAUxS20CTrgK6CIob2lu07if9Jeqo4BWymVYOPRMolT3KUOs52tfPs5SlUk3niyr-_vnHt9EDrDMMZQ0M-rMSYZTQsaHzIAPMYYA1Bg2Xizh0a75js0il2WclbwA_TB-xVA1Au6jw6ihHIKdIRurmzQzpRBNYmyVbJofRiqaWuDsUttQzLXSxXMX538Us7EW2sTY5Nrs3TKWJ3cm_DYdiGZdE4dofe1arw-3p6H6Oe387vpZTq7ubiaTmZpGfcTaS2EqkUtOKmJFopiXkGZYZ5B9QCU81LjnHBaiYrgHEidqwo0KMKJoFxXRX6IPg2-T67902kf5Nr4UjeNsrrtvGR9IrkQETx9Ba7aztm4m4zzaMEwyyL0ZYBK13rvdC2fnFkr9ywxyD51uZJ9sLIPVvapy13qchPlJ9sZ3cNaVy_ibcwR-LgFlC9VUztlS-N3HGcYExap6UD9M41-ftMK8vJ88hVi2X84HVyMD3qzc1Hut6QsZ0Tezy_k4nb24_v8diEX-X-CTKxk</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>Mulder, E.J.C.M.</creator><creator>Linssen, W.H.J.P.</creator><creator>Passchier, J.</creator><creator>De Geus, E.J.C.</creator><general>Blackwell Science Inc</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20010101</creationdate><title>Interictal and Postictal Contingent Negative Variation in Migraine Without Aura</title><author>Mulder, E.J.C.M. ; Linssen, W.H.J.P. ; Passchier, J. ; De Geus, E.J.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5269-f99af9f985f5e9a618d0c21820db0688ce13586d9d51305f3ad0e0a585968ed43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Central Nervous System - drug effects</topic><topic>Cerebral Cortex - physiopathology</topic><topic>Contingent Negative Variation</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>migraine</topic><topic>Migraine without Aura - drug therapy</topic><topic>Migraine without Aura - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Serotonin Receptor Agonists - therapeutic use</topic><topic>sumatriptan</topic><topic>Sumatriptan - pharmacology</topic><topic>Sumatriptan - therapeutic use</topic><topic>Task Performance and Analysis</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mulder, E.J.C.M.</creatorcontrib><creatorcontrib>Linssen, W.H.J.P.</creatorcontrib><creatorcontrib>Passchier, J.</creatorcontrib><creatorcontrib>De Geus, E.J.C.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mulder, E.J.C.M.</au><au>Linssen, W.H.J.P.</au><au>Passchier, J.</au><au>De Geus, E.J.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interictal and Postictal Contingent Negative Variation in Migraine Without Aura</atitle><jtitle>Headache</jtitle><addtitle>Headache: The Journal of Head and Face Pain</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>41</volume><issue>1</issue><spage>72</spage><epage>78</epage><pages>72-78</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><coden>HEADAE</coden><abstract>Cortical hyperexcitability is thought to explain the more enhanced contingent negative variation (CNV) amplitudes and impaired CNV habituation that have been found during the interictal period in migraine without aura. These CNV characteristics have been shown to normalize to the level of healthy controls during an attack. This study aimed to replicate the interictal findings, and additionally examine whether migraineurs show reduced CNV amplitudes during the postattack period. Of 12 patients with migraine without aura and their sex‐ and age‐matched healthy controls, CNV characteristics were recorded once in an interictal period, once during the postattack period within 30 hours after an attack that was treated with sumatriptan, and once after an attack that was treated with habitual nonvasoactive medication (counterbalanced). The present results did not confirm the enhanced CNV early and late wave amplitudes or impaired habituation, and cortical hyperexcitability that have previously been reported in the interictal period in patients with migraine without aura. During the postattack period, a decrease in CNV early and late amplitudes was found but only after sumatriptan use. This reduction in CNV amplitudes was most prominent over the frontal cortex and could reflect cortical hypoexcitability, possibly related to a suppression of central catecholaminergic activity by sumatriptan.</abstract><cop>Boston, MA, USA</cop><pub>Blackwell Science Inc</pub><pmid>11168606</pmid><doi>10.1046/j.1526-4610.2001.111006072.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0017-8748 |
ispartof | Headache, 2001-01, Vol.41 (1), p.72-78 |
issn | 0017-8748 1526-4610 |
language | eng |
recordid | cdi_proquest_miscellaneous_70607399 |
source | Wiley-Blackwell Journals; MEDLINE |
subjects | Adult Biological and medical sciences Cardiovascular system Central Nervous System - drug effects Cerebral Cortex - physiopathology Contingent Negative Variation Female Humans Male Medical sciences migraine Migraine without Aura - drug therapy Migraine without Aura - physiopathology Pharmacology. Drug treatments Serotonin Receptor Agonists - pharmacology Serotonin Receptor Agonists - therapeutic use sumatriptan Sumatriptan - pharmacology Sumatriptan - therapeutic use Task Performance and Analysis Vasodilator agents. Cerebral vasodilators |
title | Interictal and Postictal Contingent Negative Variation in Migraine Without Aura |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A05%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interictal%20and%20Postictal%20Contingent%20Negative%20Variation%20in%20Migraine%20Without%20Aura&rft.jtitle=Headache&rft.au=Mulder,%20E.J.C.M.&rft.date=2001-01-01&rft.volume=41&rft.issue=1&rft.spage=72&rft.epage=78&rft.pages=72-78&rft.issn=0017-8748&rft.eissn=1526-4610&rft.coden=HEADAE&rft_id=info:doi/10.1046/j.1526-4610.2001.111006072.x&rft_dat=%3Cproquest_cross%3E74823280%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218647172&rft_id=info:pmid/11168606&rfr_iscdi=true |